Safety Shot, Inc. (Nasdaq: SHOT) ("Safety Shot” or "the Company”) today announced an expected surge in revenue growth projected to exceed approximately 50% in Q4 2024 over Q3 of 2024. This projected ...
PALO ALTO, CA / ACCESSWIRE / December 12, 2024 / 180 Life Sciences Corp. ("180" or the "Company") is pleased to announce that it has regained compliance with Nasdaq Listing Rule 5605(c)(2), which requ ...
We reiterate our financial policy of no share repurchases or material cash acquisitions until we are below 2.5 net leverage, or there is a meaningful market event that would necessitate us using it.